USA, multiple locations - 10 Sep `20Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

 

Official Title: Multi-Arm Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

In Brief: This is a prospective study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

Ages Eligible: 18 Years and older 

Start Date: September 10, 2020

Completion Date (estimated): March 2023

Status: Recruiting

Study ID from ClinicalTrials.gov: NCT04547998
Other Study ID Numbers: CTP009

Locations:

  • Irvine, CA
  • Greenwood Village, CO
  • Miami, FL
  • Worcester, MA
  • Detroit, MI

Contact: To learn more about this study, you or your doctor may contact 

Elizabeth Kirshner
6613676869
ekirshner@avitamedical.com
 
Lisa Carothers
6614814663
lcarothers@avitamedical.com

Please refer to this study by its NCT number.

FAQOther Questions

  • Can Ayurveda help with vitiligo?

    People have used herbs and natural remedies to treat skin conditions for centuries. Vitiligo is an auto-immune condition that causes white patches of skin to develop and expand...

  • Is vitiligo contagious?

    Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting next to someo...

  • Isn't it just a cosmetic disorder?

    Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems, with multiple comorbidities. Fo...